Another insurance company continues to rate the WVU Cancer Institute Osborn Hematopoietic Malignancy and Transplantation Program as excellent. Highmark Blue Cross Blue Shield in West Virginia recently notified the program that it has received the company’s Blue Distinction Centers for Transplants Designation, which denotes commitment to delivering quality specialty care safely, effectively and cost efficiently. This marks the second consecutive time the Cancer Institute has received the designation from Highmark. “This validates that our program continues to provide superior care,” Sonia Leadmon, oncology quality coordinator at the Cancer Institute Mary Babb Randolph Cancer Center, said.
The health insurer took into consideration patient volume, transplant quality outcomes and additional accreditations the program has previoulsly received from other agencies.
Five undergraduate students have been selected to participate in the Summer Research Fellowship Program this year at the WVU Cancer Institute.
Cancer Prevention and Control at the WVU Cancer Institute presents Mandi Chapman, MA discussing cultural sensitivity for LGBTQI patients in this newly created web course. As the Associate Center Director, Patient-Centered Initiatives and Health Equity for the George Washington Cancer Center, Ms. Chapman’s research focuses on patient navigation, cancer survivorship and health equity for lesbian, gay, bisexual, transgender, queer and intersex (LGBTQI) communities. Originally recorded at the WVU Health Sciences Center, the presentation:
More than 100 people from the Morgantown area took advantage of this year’s skin cancer screening at the Cancer Institute’s Mary Babb Randolph Cancer Center last Thursday. Several of them, like Sara Moreland participate in the screening every year.